Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exenatide in New Onset Type 1 Diabetes
NCT01269034Phase 4Completed
- Sponsor
- Albert Einstein College of Medicine
- Start
- Dec 2010
- Primary completion
- Jan 2017
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of exenatide in type 1 diabetes mellitus (T1D), sponsored by Albert Einstein College of Medicine. Started Dec 2010; status: completed.
02
Drugs
exenatide
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT01269034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01269034.